COMMUNIQUÉS West-GlobeNewswire

Fiasp® is effective at controlling blood sugar levels in children and adolescents living with type 1 diabetes, when compared to conventional insulin aspart
12/10/2018
Hyderabad, India, 12 October 2018 - For children and adolescents (1 to <18 years old) living with type 1 diabetes, Fiasp ® (an ultra-fast acting formulation of insulin aspart) could be an option to better manage [...]
GUERBET : Mise à disposition du Rapport Financier semestriel 2018
12/10/2018
Villepinte, le 12 octobre 2018 - Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l'imagerie médicale, annonce ce jour avoir mis à la disposition du public et déposé auprès de [...]
Rule 2.9 Announcement
12/10/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 12 October 2018 [...]
Kiadis Pharma provides regulatory and clinical update on ATIR101
12/10/2018
Potential CHMP opinion moved from Q4 2018 into H1 2019 Guidance for initial EU commercial launch in H2 2019 unchanged FDA meeting held under RMAT status Phase 3 study on track with over 20 open sites expected by end [...]
Veritas Pharma Attending CannX International Medical Cannabis Conference in Tel Aviv, Israel
11/10/2018
VANCOUVER, British Columbia, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company”) is pleased to announce that its CEO Dr. Lui Franciosi and [...]
Abattis Bioceuticals Provides Update on Vaporizer Product Line
11/10/2018
VANCOUVER, British Columbia, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “ Company " or " Abattis ") (CSE:ATT) (OTC:ATTBF) is pleased to announce an update on our recent product line addition of [...]
Trevena Announces Oliceridine FDA Advisory Committee Meeting Outcome
11/10/2018
CHESTERBROOK, Pa., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN), today announced the outcome of the meeting of the U.S. Food and Drug Administration (FDA) Anesthetic and Analgesic Drug Products [...]
Sandoz announces global resolution of biosimilar adalimumab patent disputes, securing patient access
11/10/2018
Global resolution secures patient access to Sandoz biosimilar Hyrimoz ® (adalimumab)[1] for the reference medicine Humira ® ** Resolution paves way for 2018 launch in key European markets and secures US market entry [...]
Align Technology Expands Invisalign Interactive Brand Experience Pilot Program to Connect More Consumers With Invisalign Doctors
11/10/2018
8 New Invisalign Experience Locations in Q4 to Connect Consumers with Invisalign Doctors Designed to Address 300+ Million Consumer Market for Clear Aligner Orthodontics Invisalign Experience Pilot Locations Show [...]
Integra LifeSciences to Host Third Quarter 2018 Earnings Results Conference Call on October 31, 2018
11/10/2018
PLAINSBORO, N.J., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2018 financial results on Wednesday, [...]
KemPharm Provides Highlights from KOL Investor Event Focused on the ADHD Treatment Landscape
11/10/2018
Event Held Today, October 11, 2018 CORALVILLE, Iowa, Oct. 11, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, [...]
Iovance Biotherapeutics, Inc. Announces Proposed Public Offering of Common Stock
11/10/2018
SAN CARLOS, Calif., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (Nasdaq:IOVA) (“Iovance” or “Company”), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating [...]
Corium Announces Agreement for Gurnet Point Capital to Purchase All Outstanding Shares
11/10/2018
Total Transaction Valued in Excess of $500 Million, Representing a 50% Premium Gurnet Point Capital to Expand Operations While Focusing on the Approval and Commercialization of Corium’s Corplex Donepezil MENLO PARK, [...]
Iovance Biotherapeutics Reports Results from FDA End of Phase 2 meeting and Provides Updates About the Company’s Clinical Program
11/10/2018
—FDA acknowledged acceptability of a single-arm cohort for registration in metastatic melanoma post PD-1 blocking antibody and, if BRAF mutation positive, a BRAF inhibitor or BRAF inhibitor with MEK inhibitor —FDA [...]
Progenics Advances 1095, PSMA-Targeted Therapeutic Candidate for the Treatment of Metastatic Prostate Cancer, into Phase 2 Clinical Development Following Discussions with the FDA
11/10/2018
– Trial will utilize PyL imaging in order to target the patients most likely to benefit, advancing the Company’s theranostic approach to the treatment of prostate cancer – NEW YORK, Oct. 11, 2018 (GLOBE NEWSWIRE) -- [...]
Tetraphase Pharmaceuticals Announces Commercial Launch of XERAVA™ in the United States
11/10/2018
FDA-Approved for the Treatment of Complicated Intra-Abdominal Infections Provides Broad Spectrum of Coverage Against Gram-negative, Gram-positive, and Anaerobic Bacteria for a Range of Patients with Empiric and [...]
Immune Design Announces Program Updates & Portfolio Prioritization for G100 and CMB305
11/10/2018
G100 development to accelerate in follicular lymphoma and beyond CMB305 to be deprioritized to support focus on G100 Cash runway extended into 2021 Conference call at 2:00 pm Pacific today SEATTLE and SOUTH SAN [...]
Chimerix to Host Annual Investor Update on October 17, 2018
11/10/2018
DURHAM, N.C., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced that it will host the Company's annual [...]
NSS Labs Announces 2018 Breach Detection Systems Group Test Results
11/10/2018
Three Products Receive Recommended Rating; Two Products Miss at Least One Evasion AUSTIN, Texas, Oct. 11, 2018 (GLOBE NEWSWIRE) -- NSS Labs, Inc., a global leader and trusted source for independent, fact-based [...]

Pages